Logo

Epic Sciences: William Kullback, Joel Smith

Nov 01, 2022

Epic Sciences, a developer of diagnostic tests to guide cancer therapy selection and monitor disease progression, has appointed William Kullback as CFO. Previous CFO Joel Smith will continue in his other executive roles as general counsel, chief compliance officer, and executive VP of corporate development.

Kullback has 27 years of experience as a CFO. Prior to joining Epic, he was CFO of BioLegend until the $5.25 billion sale of that company to PerkinElmer. Before BioLegend, Kullback was at Lombard Medical. He earned hs MBA and bachelor's degrees from the State University of New York at Buffalo.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.